In malignancies, CTLA-4 expressed by tumour cells is supposed to facilitate tumour cell evasion by ablating the immune surveillance of immune cells (ICs) around the tumour because CTLA-4 inhibition results in increased activation of the immune system. The gene discussed is CTLA4; the disease is neoplasm.